For much of the past year, the UK’s medicines pricing debate has cast a long shadow over the life sciences sector. The deadlock over NHS rebates – and the uncertainty surrounding the successor to VPAG ...
Following the money comes pretty naturally to carmakers. It’s what happens when the product planning department smells ...
Invest in stocks or mutual funds depending on research preference and time availability. Allocate assets based on age, investing more in stocks when younger and in bonds as you age. Open a brokerage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results